Androgen receptor-binding sites are highly mutated in prostate cancer
Androgen receptor (AR) mediated transcription is critical to prostate tumorigenesis and development. Here, utilising clinical whole genome sequencing data, the authors show that the non-coding AR binding sites on DNA are frequently mutated in prostate cancer potentially due to faulty base excision r...
Main Authors: | Tunç Morova, Daniel R. McNeill, Nada Lallous, Mehmet Gönen, Kush Dalal, David M. Wilson, Attila Gürsoy, Özlem Keskin, Nathan A. Lack |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2020-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-14644-y |
Similar Items
-
Androgen Receptor-Mediated Transcription in Prostate Cancer
by: Doğancan Özturan, et al.
Published: (2022-03-01) -
Deep Learning Modeling of Androgen Receptor Responses to Prostate Cancer Therapies
by: Oliver Snow, et al.
Published: (2020-08-01) -
Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer
by: Fuqiang Ban, et al.
Published: (2021-07-01) -
Development of Novel Inhibitors Targeting the D-Box of the DNA Binding Domain of Androgen Receptor
by: Mariia Radaeva, et al.
Published: (2021-03-01) -
Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors
by: Mariia Radaeva, et al.
Published: (2022-09-01)